Generally, MM is detected by the presence of epithelial markers present in the lymph nodes, usually by cytokeratins (CKs), carcinoembryonic antigen (CEA), mucins and squamous-cell carcinoma-related antigen (SCC), but sometimes it is missed in the routine IHCs [22]. Here, CEACAM5 is linked to Miyoshi myopathy.